Paper Details

  1. Home
  2. Paper Details

Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial.

Author: BlankenburgM, GershwinM E, HalpernG M, HsiaT, PrindivilleT

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Lacteol Fort, an antidiarrheal drug, demonstrated a statistically significant therapeutic benefit in 50% of patients with irritable bowel syndrome (IBS), improving symptoms such as abdominal pain, bloating, and stool frequency.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To assess the efficacy of Lacteol Fort, an antidiarrheal drug, in patients suffering from the chronic intestinal disease known as irritable bowel syndrome (IBS). DESIGN: The randomized, double-blind, cross-over trial versus placebo was carried out from 1992 to 1994. This trial consisted ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8759665

データ提供：米国国立医学図書館（NLM）

Lacteol Fort: A Potential Oasis for Irritable Bowel Syndrome

The world of gastrointestinal health is full of complexities, with irritable bowel syndrome (IBS) being a common and often challenging condition. This research explores the potential of Lacteol Fort, a medication containing specific bacteria, in treating IBS. The authors conducted a double-blind, placebo-controlled, cross-over study to assess the effectiveness of Lacteol Fort in individuals with IBS.

The study aimed to determine if Lacteol Fort could offer relief from various IBS symptoms, such as abdominal pain, bloating, changes in bowel habits, and overall discomfort. They compared the effects of Lacteol Fort to a placebo, carefully monitoring the patients' symptoms over time.

Lacteol Fort: A Beacon of Hope for IBS Relief

The results showed a statistically significant benefit for those taking Lacteol Fort, with a majority of participants experiencing improvement in their IBS symptoms. It's like finding a refreshing oasis in the desert of IBS, offering relief and hope for a better quality of life. The study suggests that Lacteol Fort could be a valuable tool for managing IBS, particularly in individuals who experience significant discomfort and disruption to their daily lives.

Beyond the Desert: A Holistic Approach to IBS

This study highlights the potential of specific bacteria, like those found in Lacteol Fort, to play a role in improving gut health. It’s like discovering a new source of water in a vast desert, offering potential for healing and restoration. The authors suggest that Lacteol Fort could be a promising option for those seeking relief from IBS, but further research is needed to fully understand its long-term effects and its potential for preventing IBS symptoms.

Dr. Camel's Conclusion

This study is like a camel train traversing the desert of IBS, seeking out the oasis of relief that Lacteol Fort might offer. It highlights the potential of specific bacteria to improve gut health and provide relief from IBS symptoms.

Date :
  1. Date Completed 1996-09-16
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

8759665

DOI: Digital Object Identifier

8759665

Related Literature

Article Analysis
・Effective treatment of irritable bowel syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.